WEBINAR with Verve Therapeutics: Design & develop gene therapies on a unified digital platform
REGISTER
Products
The Benchling Difference: The Life Sciences R&D Cloud
Applications
Notebook
Record your experiments 85% faster
Molecular Biology
Comprehensive design tools for DNA, oligonucleotides, and AA sequences
Registry
Model anything. Track everything
Inventory
A digital window into your physical lab
Requests
A single system for request submission and fulfillment
Workflows
Organize, optimize, and measure your R&D processes
Insights
Intelligence to power your R&D
PLATFORM
Benchling for Lab Automation
Unlock the full power of your lab instruments
Validated Cloud
Accelerate R&D in a compliant environment
Codeless Configuration
The benefits of custom, the ease of off-the-shelf
Developer Platform
Bring together all your R&D data
CUSTOMER SUCCESS
Services
We're your life science R&D experts
Solutions
INDUSTRY
Biopharmaceutical
Industrial Biotech
Agritech
THERAPEUTIC TYPE
Antibodies
Cell Therapy
Gene Therapy
RNA Therapeutics
ACADEMIC
Researchers
Educators
Customers
Meet our Customers
Customer Stories
Pricing
Pricing
Other Programs
For Academics
For Institutions
For Startups
Resources
Content Library
Benchling Support
Blog
COVID-19 Resources
Company
About Benchling
Trust
Events
In the News
Partnerships
Careers
Contact Us
Already a user?
Sign In
Sign Up
Request a Demo
Month:
September 2020
Benchling
Introducing New Antibody Property Prediction Tools
Scientist Spotlight
A Unique Approach To Antibody Discovery with Dr. Aaron Sato, CSO of Twist Biopharma
Benchtalk Journal Vol. 5 Leadership in Life Science
Research
SARS-CoV-2 and the Human Body: New Evidence of How Our Immune System Fights Back